<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03552367</url>
  </required_header>
  <id_info>
    <org_study_id>DI/17/311/03/028</org_study_id>
    <nct_id>NCT03552367</nct_id>
  </id_info>
  <brief_title>Structured Exercise Prescription Program in Obese Children</brief_title>
  <official_title>Efficacy of a Structured Exercise Prescription Program Over Anthropometric, Metabolic and Fitness Parameters in Obese Children and Adolescents Included in a Multicomponent Lifestyle Intervention Program. Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General de México Dr. Eduardo Liceaga</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Council of Science and Technology, Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundacion Sertull</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universidad Nacional Autonoma de Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital General de México Dr. Eduardo Liceaga</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This controlled clinical trial aims to compare the effects of a multicomponent program that
      includes structured personalized exercise prescription in children with obesity with a
      control group that will be enrolled in a multicomponent program without structured
      personalized exercise prescription. All children will be followed for a period of 6 months.

      The parameters that will be evaluated between groups are physical fitness, anthropometry,
      metabolic (glucose oral tolerance curve, lipids, HOMA-IR, ISI-MATSUDA), early cardiovascular
      damage, inflammatory biomarkers, anxiety and depression scores, and allelic variants related
      to physical fitness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This controlled clinical trial aims to compare the effects of a multicomponent program that
      includes structured personalized exercise prescription in children with obesity (study group)
      with a control group that will be enrolled in a multicomponent program without structured
      personalized exercise prescription. All children will be followed for a period of 6 months.

      The parameters that will be evaluated between groups are physical fitness (measured by
      VO2max, ECG at rest, biomechanics and dynamometry), anthropometric measurements (weight
      height, BMI, plicometry, bioimpedance, metabolic (glucose oral tolerance curve, lipids,
      HOMA-IR, ISI-MATSUDA), early cardiovascular damage (carotid intima-media thickness,
      atherogenic dyslipidemia), inflammatory biomarkers (leptin, adiponectin, IL-17, IL-10,
      INF-gamma, IL-6, IL-12, y TNF-alpha), anxiety and depression scores evaluated with Child
      Depression Inventory (CID) and -Trait Anxiety Inventory for Children (STAI-CH), and allelic
      variants related to physical fitness (ACTN, TRH2 y FTO).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">July 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized open clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>This is an open-label trial</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>VO2 max</measure>
    <time_frame>6 months</time_frame>
    <description>Changes in VO2 max as fitness indicator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>OGTT</measure>
    <time_frame>6 months</time_frame>
    <description>Oral glucose tolerance test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>6 months</time_frame>
    <description>BMI zScore</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AST</measure>
    <time_frame>6 months</time_frame>
    <description>AST</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ALT</measure>
    <time_frame>6 months</time_frame>
    <description>ALT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GGT</measure>
    <time_frame>6 months</time_frame>
    <description>GGT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leptin</measure>
    <time_frame>6 months</time_frame>
    <description>Leptin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adiponectin</measure>
    <time_frame>6 months</time_frame>
    <description>Adiponectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lean body mass</measure>
    <time_frame>6 months</time_frame>
    <description>Lean body mass</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Obesity</condition>
  <condition>Exercise</condition>
  <condition>Cardiovascular Risk Factor</condition>
  <condition>Liver Diseases</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Childhood Obesity</condition>
  <arm_group>
    <arm_group_label>Personalized structured exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will be enrolled in a multicomponent program for obese children (8-12 years old) that includes intervention workshops concerning nutrition, emotional factors, cognitive therapy and personalized structured exercise prescription that will be offered on-site and online and monitored through the use of heart rate monitoring devices. The type of exercise offered to patients in this arm is precisely designed for obese patients according to age and physical fitness parameters.
Intervention: Non-personalized non-structured exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-personalized non-structured exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will be enrolled in a multicomponent program for obese children (8-12 years old) that includes intervention workshops concerning nutrition, emotional factors, cognitive therapy and non-personalized non-structured exercise prescription Intervention: Non-personalized non-structured exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Personalized structured exercise program</intervention_name>
    <description>The type of exercise offered to patients in this arm is precisely designed for obese patients according to age and physical fitness parameters. Patients are monitored using a heart rate monitor to evaluate treatment adherence and compliance</description>
    <arm_group_label>Personalized structured exercise</arm_group_label>
    <other_name>Structured exercise</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non personalized non-structured exercise program</intervention_name>
    <description>The type of exercise is non-structured and patients' heart rate is not monitored. Patients receive exercise recommendations without any personalization according to their fitness parameters</description>
    <arm_group_label>Non-personalized non-structured exercise</arm_group_label>
    <other_name>Non-structured exercise</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients with BMI ≥ Pc 95 and &lt; 35kg/m2 Both sexes Accepts to
        participate and signs informed consent

        Exclusion Criteria:

        Presence of endocrine disease including type I and II diabetes mellitus Presence of
        arterial hypertension Presence of primary dyslipidemia Presence of infections at moment of
        enrollment Presence of systemic disease Presence of genetic disorder Medical treatment that
        may interfere with lipid or glucose metabolism Prolonged or acute immobilization
        Participated in a previous similar intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nayely Garibay Nieto, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director Child and Adolescent Obesity Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nayely Garibay Nieto, MD MSc</last_name>
    <phone>+5255 2789 2000</phone>
    <email>gngaribay@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital General de Mexico Eduardo Liceaga</name>
      <address>
        <city>Mexico City</city>
        <state>Del. Cuauhtemoc</state>
        <zip>06720</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nayely Garibay iIeto, MD MSc</last_name>
      <phone>2789 2000</phone>
      <email>gngaribay@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D. Assessment of child and adolescent overweight and obesity. Pediatrics. 2007 Dec;120 Suppl 4:S193-228. Review.</citation>
    <PMID>18055652</PMID>
  </reference>
  <reference>
    <citation>American Dietetic Association (ADA). Position of the American Dietetic Association: individual-, family-, school-, and community-based interventions for pediatric overweight. J Am Diet Assoc. 2006 Jun;106(6):925-45.</citation>
    <PMID>16812927</PMID>
  </reference>
  <reference>
    <citation>Kelley GA, Kelley KS. Exercise and BMI z-score in overweight and obese children and adolescents: protocol for a systematic review and network meta-analysis of randomised trials. BMJ Open. 2016 Apr 15;6(4):e011258. doi: 10.1136/bmjopen-2016-011258.</citation>
    <PMID>27084289</PMID>
  </reference>
  <reference>
    <citation>Kelley GA, Kelley KS, Pate RR. Exercise and BMI z-score in Overweight and Obese Children and Adolescents: A Systematic Review and Network Meta-Analysis of Randomized Trials. J Evid Based Med. 2017 May;10(2):108-128. doi: 10.1111/jebm.12228. Review.</citation>
    <PMID>27792271</PMID>
  </reference>
  <reference>
    <citation>Lisón JF, Real-Montes JM, Torró I, Arguisuelas MD, Alvarez-Pitti J, Martínez-Gramage J, Aguilar F, Lurbe E. Exercise intervention in childhood obesity: a randomized controlled trial comparing hospital-versus home-based groups. Acad Pediatr. 2012 Jul-Aug;12(4):319-25. doi: 10.1016/j.acap.2012.03.003. Epub 2012 May 26.</citation>
    <PMID>22634075</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>April 24, 2018</study_first_submitted>
  <study_first_submitted_qc>June 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2018</study_first_posted>
  <last_update_submitted>June 8, 2018</last_update_submitted>
  <last_update_submitted_qc>June 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General de México Dr. Eduardo Liceaga</investigator_affiliation>
    <investigator_full_name>Nayely Garibay Nieto</investigator_full_name>
    <investigator_title>Head of the Child and Adolescent Obesity Clinic</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Children</keyword>
  <keyword>Non-alcoholic fatty acid liver disease</keyword>
  <keyword>Exercise</keyword>
  <keyword>Metabolic syndrome</keyword>
  <keyword>Cardiovascular risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Not until first article is published</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

